MDMA Failed to Receive FDA Approval: What Happens Next?
Veriheal
JUNE 26, 2025
Federal health regulators recently declined to approve the use of the psychedelic drug midomafetamine (3,4-methylenedioxymethamphetamine or MDMA) as a treatment for post-traumatic stress disorder (PTSD), disappointing many advocates who were hopeful for the next breakthrough in the psychedelic therapy movement.
Let's personalize your content